Bicyclomycin
Bicyclomycin is an antibiotic. Bicyclomycin exhibits selective antibacterial activity against Gram-negative bacteria such as Escherichia coli and Klebsiella spp., with no cross-resistance. Bicyclomycin is applicable to the research of infectious diseases.
For research use only. We do not sell to patients.
- CAS No.: 38129-37-2
- Formula: C12H18N2O7
- Molecular Weight:302.28
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
All Antibiotic Isoforms
More
Biological Activity
Description
In Vitro
Bicyclomycin (6-25 μg/mL; 2 h) induces dose-dependent morphological changes (cell elongation, spheroplast formation) in actively growing cells of E. coli strain 15 THU and the highly sensitive E. coli strain ATCC 27166[1].
Bicyclomycin (25-100 μg/mL; 0-60 min) inhibits RNA and protein synthesis in proliferating E. coli 15 THU cells, but does not affect their DNA or lipid synthesis[1].
Bicyclomycin (100 μg/mL, over 0-45 min) exerts a stronger inhibitory effect on bound lipoprotein synthesis (inhibition rate of approximately 95%) than on free lipoprotein (inhibition rate of approximately 60%) and envelope protein synthesis (inhibition rate of approximately 50%) in histidine-starved E. coli 15 THU cells, with no effect on cytoplasmic protein synthesis[1].
Bicyclomycin exhibits selective moderate antibacterial activity against specific Gram-negative bacteria (Escherichia coli NIHJ JC-2, Klebsiella pneumoniae ST-101, Salmonella typhosa T-287, Shigella flexneri 1a-2 W-A), with an MIC of 25 mcg/mL; it shows only weak activity against Sarcina lutea PCI-100 (MIC 250 mcg/mL); and it has no activity against other tested Gram-positive bacteria, Gram-negative bacteria, mycobacteria, fungi, or yeasts[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 38129-37-2
-
Appearance Solid
-
Molecular Weight 302.28
-
Formula C12H18N2O7
-
Color White to off-white
-
SMILES
OC[C@](C)(O)[C@@H]([C@]12C(N[C@](C(N1)=O)(C(CCO2)=C)O)=O)O
-
Structure Classification
-
Initial Source
sterptomyces cinnamoneus
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Gram Staining of Tissue Sections
Gram staining of tissue sections is a histochemical technique used to differentiate Gram-positive and Gram-negative bacteria within histological specimens based on differences in bacterial cell wall structure and dye retention, adapted from classical bacteriological Gram staining into tissue-compatible “histological Gram stain” variants. In tissue applications, modifications of the Brown-Hopps and Brown-Brenn methods are commonly used to improve differentiation of microorganisms embedded within host connective tissue and to reduce overstaining or loss of Gram-negative signal, which are known limitations of earlier approaches. The principle relies on crystal violet-iodine complex retention in Gram-positive organisms and subsequent decolorization and counterstaining steps that allow contrast visualization of Gram-negative organisms against tissue background.
-
Bacterial live/dead nucleic-acid viability staining
The LIVE/DEAD bacterial viability staining method is based on differential permeability of nucleic-acid-binding fluorescent dyes, most commonly SYTO 9 and propidium iodide (PI), which enables discrimination of bacterial populations with intact versus compromised cytoplasmic membranes. SYTO 9 penetrates both intact and damaged bacterial membranes and binds nucleic acids to produce green fluorescence, whereas propidium iodide penetrates only cells with compromised membranes and fluoresces red while also reducing SYTO 9 signal through competitive binding and fluorescence interactions. The resulting fluorescence pattern is interpreted as a proxy for membrane integrity, which is widely used as an indicator of bacterial viability in microscopy, flow cytometry, and spectroscopic platforms. However, mechanistic studies show that SYTO 9 and PI interactions involve displacement and fluorescence resonance energy transfer effects, which can influence signal interpretation depending on dye ratios a
Purity & Documentation
-
Data Sheet (278 KB)
-
SDS (479 KB)
- English - EN (479 KB)
- Français - FR (479 KB)
- Deutsch - DE (479 KB)
- Norwegian - NO (479 KB)
- Español - ES (479 KB)
- Swedish - SV (479 KB)
- Italian - IT (479 KB)
- Korean - KR (479 KB)
- Portuguese - PT (479 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)